Skip to content

ClearPoint Neuro, Inc.

CLPT · XNAS

CIK 1285550fmd_0RTNX26W4A6YMXQJ71816WC6TQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2026, 64 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues67711131621243137
Cost of revenue3324457101214
Net interest income––––––(0)01–
Gross profit345791114141923
Research and development33235911121214
Selling, general and administrative44445810121216
Operating income(7)(6)(5)(5)(6)(13)(16)(22)(20)(24)
Interest expense1111110–12
Interest and investment income0–––––––11
Other non-operating income (expense)00001(0)(0)(0)(0)(0)
Income before taxes––––––––(19)(25)
Income tax expense––––000000
Net income from continuing operations––––––––(19)(26)
Net income(8)(7)(6)(6)(7)(14)(16)(22)(19)(26)